Li Jiajia, Hou Sicong, Ye Ziping, Wang Wujun, Hu Xiaolin, Hang Qinglei
Department of Gastroenterology, The Affiliated Hospital of Yangzhou University, Yangzhou 225009, China.
Department of Clinical Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Cancers (Basel). 2022 Apr 24;14(9):2115. doi: 10.3390/cancers14092115.
Despite tremendous efforts devoted to research in pancreatic cancer (PC), the mechanism underlying the tumorigenesis and progression of PC is still not completely clear. Additionally, ideal biomarkers and satisfactory therapeutic strategies for clinical application in PC are still lacking. Accumulating evidence suggests that long non-coding RNAs (lncRNAs) might participate in the pathogenesis of diverse cancers, including PC. The abnormal expression of lncRNAs in PC is considered a vital factor during tumorigenesis that affects tumor cell proliferation, migration, invasion, apoptosis, angiogenesis, and drug resistance. With this review of relevant articles published in recent years, we aimed to summarize the biogenesis mechanism, classifications, and modes of action of lncRNAs and to review the functions and mechanisms of lncRNAs in PC. Additionally, the clinical significance of lncRNAs in PC was discussed. Finally, we pointed out the questions remaining from recent studies and anticipated that further investigations would address these gaps in knowledge in this field.
尽管在胰腺癌(PC)研究方面付出了巨大努力,但PC发生发展的潜在机制仍不完全清楚。此外,仍缺乏用于PC临床应用的理想生物标志物和令人满意的治疗策略。越来越多的证据表明,长链非编码RNA(lncRNAs)可能参与包括PC在内的多种癌症的发病机制。lncRNAs在PC中的异常表达被认为是肿瘤发生过程中的一个重要因素,它会影响肿瘤细胞的增殖、迁移、侵袭、凋亡、血管生成和耐药性。通过对近年来发表的相关文章进行综述,我们旨在总结lncRNAs的生物发生机制、分类和作用模式,并综述lncRNAs在PC中的功能和机制。此外,还讨论了lncRNAs在PC中的临床意义。最后,我们指出了近期研究中存在的问题,并预计进一步的研究将填补该领域的这些知识空白。